Support a pragmatic clinical trial programme by cancer charities
This EU funding program, HORIZON-MISS-2024-CANCER-01-04, aims to bolster pragmatic clinical trial programs specifically by cancer charities. It seeks to coordinate and network these charities and relevant stakeholders across Europe to foster multi-centre, transnational pragmatic clinical trials focused on difficult-to-treat and rare cancers. The initiative is part of the broader EU Mission on Cancer, striving to improve cancer care and patient outcomes by facilitating accessible and evidence-based treatment solutions.
Who is Funded
This section details the eligibility criteria for the "Support a pragmatic clinical trial programme by cancer charities" funding program, outlining which entities can apply, the geographical scope of the supported activities, and the overarching objectives of this vital initiative within the EU Mission on Cancer. The program specifically targets collaborative efforts across Europe to advance patient-centered research in oncology.
What is Funded
This section outlines the types of projects, thematic areas, and specific activities eligible for funding under the "Support a pragmatic clinical trial programme by cancer charities" initiative. It also clarifies what costs are covered and the developmental stage of the projects that the program aims to support, with a strong emphasis on real-world impact and evidence-based interventions.
Type and Scope of Funding
This section details the financial aspects of the "Support a pragmatic clinical trial programme by cancer charities" program, including the type of financial support offered, the maximum funding available per project, and relevant financial conditions.
Conditions and Requirements
This section outlines the essential rules and conditions that applicants and beneficiaries must adhere to for the "Support a pragmatic clinical trial programme by cancer charities" funding program. It covers application terms, collaboration guidelines, and other important provisions ensuring proper implementation and compliance.
Application Procedure
This section outlines the application process for the "Support a pragmatic clinical trial programme by cancer charities" program, detailing the steps for submission, evaluation criteria, and how funding decisions are communicated to applicants.
Legal Basis
This section identifies the foundational legal and official documents that underpin the "Support a pragmatic clinical trial programme by cancer charities" funding program, situating it within the broader European Union legal framework.
Similar Programs
Funding Overview
Funding Status:
Closed
Maximum Amount:
3.000.000,00 €
Allocated Budget:
3.000.000,00 €
Award Channel:
Framework Programme Call
Region:
European Union and Associated Countries (requiring representation from Northern, Central, Southern, Eastern, and Western Europe)
Sectors:
Healthcare, Medical Technology, Research and Development, Information and Communication Technology, Social Enterprises
Beneficiaries:
Cancer patients, caregivers, researchers, innovators, professionals, national healthcare providers, policymakers, authorities
Application Type:
Consortium Required
Funding Stages:
Applied Research, Experimental Development, Pilot Testing, Implementation, Service Delivery, Capacity Building
Funding Provider
Program Level:
European Union
Funding Body:
European Commission
Additional Partners:
Academic investigator-led third parties, citizen representatives, stakeholders across Member States and Associated Countries. The Knowledge Centre on Cancer (KCC) hosted by the European Commission's Joint Research Centre (JRC) will support EU alignment and coordination. Projects will join the 'Diagnostics and Treatment' cluster for the Mission on Cancer.
Website: